期刊文献+

胰岛素样生长因子1受体及其通路在原发性肝癌中的机制及进展 被引量:2

Research advances in insulin-like growth factor 1 receptor and its pathway in diagnosis and treatment of primary liver cancer
下载PDF
导出
摘要 胰岛素样生长因子1受体(IGF-1R)的生物学功能主要表现为形成并维持细胞的转化表型,参与细胞增殖、分化,抑制细胞的凋亡。除此之外,IGF-1R对细胞周期具有调节作用,与表皮生长因子、血小板衍生生长因子共同作用,介导细胞周期从G1期进入S期。过度表达的IGF-1R己经成为原发性肝癌影像诊断及定位治疗的热点靶蛋白之一。抑制IGF-1R的表达或功能可有效控制肿瘤细胞生长和转移,并增强其对化疗、放疗的敏感性。综述了IGF-1R及其通路在原发性肝癌诊断及治疗中的作用及意义。 The main biological functions of insulin - like growth factor 1 receptor ( IGF - 1 R) include formation and maintenance of transformed cell phenotype, involvement in cell proliferation and differentiation, and inhibition of cell apoptosis. In addition, IGF - 1 R regulates cell cycle and works with epidermal growth factor and platelet - derived growth factor to mediate cells to enter S phase from G1 phase. Overexpressed IGF - 1 R has become one of the target proteins for diagnostic imaging and localization therapy for primary liver cancer. Inhibition of the expression or function of IGF - 1 R can effectively control the growth and metastasis of tumor cells and enhance their sensitivity to chemotherapy and radiotherapy. This article reviews the role and significance of IGF - 1 R and its pathway in the diagnosis and treatment of primary fiver cancer.
出处 《临床肝胆病杂志》 CAS 2017年第4期763-768,共6页 Journal of Clinical Hepatology
关键词 肝肿瘤 受体 IGF1型 诊断 治疗 综述 liver neoplasms receptor, IGF type 1 diagnosis therapy review
  • 相关文献

参考文献2

二级参考文献186

  • 1Pollak M. Insulin and insulin-like growth factor signalling in neoplaeia. Nat Rev Cancer, 2008,8:915-928.
  • 2Frasca F, Pandini G, Sciacca L, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem, 2008,114:23-37.
  • 3Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer, 2004,4:505- 518.
  • 4Moschos S J, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncol, 2002,63:317-332.
  • 5Baserga R. The IGF-I receptor in cancer research. Exp Cell Res, 1999,253:1-6.
  • 6Clemmons DR. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol, 2006,6: 620-625.
  • 7LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab, 2007,3:302-310.
  • 8Nickerson T, Chang F, Lorimer D, et al. In vivo progression el LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and GFq receptor (IGF-IR). Cancer Res. 2001.61:6276-6280.
  • 9Cullen K J, Yee D, Sly WS, et al. receptor expression and function in Cancer Res. 1990.50:48-53.
  • 10nsulin-like growth factor human breast cancer. Gooch JL, Van Den Berg CL, Yee D. Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects. Breast Cancer Res Treat. 1999,56:1-10.

共引文献46

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部